The Bristol Herald Courier thinks this will surprise people. If you did not know this you must be living under a rock. My fellow ODBA members Adam and Scott have some thoughts on this. While the process is not perfect, … Continue reading →

My colleague Chris Tisch, who has written extensively about the abuse of prescription drugs in Florida, reports today that a bill in the Legislature to track prescriptions through a statewide monitoring system is running into trouble. The measure is House … Continue reading →

East Bay Funk Punk Posted on Mon Mar 31, 2008 at 10:11:01 AM EST in NBA More on: Isaiah Rider, crime, car, NBA (all tags) Remember when Isaiah Rider used to be one of the most talented up-and-comers in the … Continue reading →

New data about the controversial cholesterol fighter Vytorin failed to quell touching to that the drug might not be as good as thought at keeping heart disease at bay, leading an expert panel to recommend on Sunday that patients stick … Continue reading →

The human body has a complex mechanism that causes blood to clot if a wound occurs – a desirable response under normal circumstances. But under certain clinical conditions, known as thrombotic disorders, this same mechanism can cause an unwanted clot … Continue reading →

Healing the Mind – Body SplitIdeological Foolishness A New Series—On Clinging “Who gave you the right to your own opinion??” (Photo by Alaskan Dude) As we end our series on clinging, we turn to ideologies. First, a definition: Ideology: Most … Continue reading →

Who’s your daddy? Answer’s at the drugstore Pharmacy chain markets DNA paternity tests in 30 states nationwide By JoNel Aleccia Health writer MSNBC updated 8:36 a.m. ET, Thurs., March. 27, 2008 After two decades, Sean Reid of Surrey, British Columbia, … Continue reading →

clipped from blogs.wsj.comThe discussion of that big Vytorin study at this weekend’s big cardiology meeting was harsher than expected. Industry observers had predicted that an open conversation by the experts could temper the negative image of the drug that emerged … Continue reading →

Since 2002, when the first patient was enrolled in the controversial Enhance trial of the cholesterol drug Vytorin, Dutch researcher John Kastelein had been looking forward to presenting the findings to a lecture hall packed with thousands of other heart … Continue reading →

HealthDay – SUNDAY, March 30 (HealthDay News) — A divided cardiology community is trying once again to make sense of a trial showing that a drug can lower levels of “bad” LDL thin and yet give no apparent benefit to … Continue reading →